Cart summary

You have no items in your shopping cart.

KRAS G12C inhibitor 37

SKU: orb1744963

Description

KRAS G12C Inhibitor 37 is a selective small molecule targeting the oncogenic KRAS G12C mutant protein, a key driver in cellular proliferation pathways. It is a valuable research tool for investigating KRAS-driven cancers, with utility demonstrated in both in vitro cellular assays and in vivo preclinical tumor models.

Research Area

Pharmacology & Drug Discovery, Signal Transduction

Images & Validation

Key Properties

CAS Number2241720-04-5
MW660.73
FormulaC35H39F3N8O2
SMILESC(C=C)(=O)N1CC2(C1)CCN(CC2)C=3C4=C(C(OCC(F)(F)F)=C(C(C=C)=C4)C5=C6C(=CC=C5C)NN=C6)N=C(N3)N7CC(N(C)C)C7
TargetRas,Others,Kras

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • KRAS inhibitor-37 [orb2695292]

    3058573-95-5

    618.10

    C32H33ClFN7O3

    50 mg, 25 mg, 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

KRAS G12C inhibitor 37 (orb1744963)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%